Thoracic tuberculosis: clinical aspects.

[1]  C. Grönhagen-Riska,et al.  Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. , 2015, The American review of respiratory disease.

[2]  G. Comstock,et al.  The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. , 2015, The American review of respiratory disease.

[3]  R. Loudon,et al.  Cough frequency and infectivity in patients with pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[4]  D. Girling,et al.  The hepatic toxicity of isoniazid among rapid and slow acetylators of the drug. , 1978, The American review of respiratory disease.

[5]  D. Cugell.  Sounds of the lungs. , 1978, Chest.

[6]  D. Solomon,et al.  Isoniazid chemoprophylaxis. Association with detection and incidence of liver toxicity. , 1977, Archives of internal medicine.

[7]  A. R. Somner,et al.  Short-course chemotherapy in pulmonary tuberculosis. , 1977, Bulletin of the International Union against Tuberculosis.

[8]  D. Solomon,et al.  Treatment of tuberculosis by the nonpulmonary physician. , 1977, Annals of internal medicine.

[9]  J. Pilheu.  Short-duration treatment of pulmonary tuberculosis. , 1977, Chest.

[10]  A. Rouillon,et al.  Transmission of tubercle bacilli: The effects of chemotherapy. , 1976, Tubercle.

[11]  U. Thorgeirsson,et al.  Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. , 1976, Annals of internal medicine.

[12]  K. Toman.  Mass radiography in tuberculosis control. , 1976, WHO chronicle.

[13]  L. Reichman.  Tuberculosis screening and chest x-ray films. , 1975, Chest.

[14]  W. Stead.  Goals and productivity of tuberculosis screening. , 1975, Chest.

[15]  P. Q. Edwards.  Screening for tuberculosis. , 1975, Chest.

[16]  D. Zavala.  Diagnostic fiberoptic bronchoscopy: Techniques and results of biopsy in 600 patients. , 1975, Chest.

[17]  I. Light,et al.  Management of newborns after nursery exposure to tuberculosis. , 1974, The American review of respiratory disease.

[18]  R. Loudon.  The place of rifampin. , 1972, Chest.

[19]  J. Raleigh.  Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study. , 1972, The American review of respiratory disease.

[20]  P. Stradling,et al.  Potentially Serious Side Effects of High-dose Twice-weekly Rifampicin , 1971, British medical journal.

[21]  J. Sbarbaro,et al.  Supervision of outpatient drug therapy with the medication monitor. , 1970, Annals of internal medicine.

[22]  J. Smith,et al.  Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. , 1969, Annals of internal medicine.

[23]  G. Canetti,et al.  Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results. , 1969, Tubercle.

[24]  R. Loudon,et al.  Chemoprophylaxis for the prevention of tuberculosis. , 1968, The Journal of the Oklahoma State Medical Association.

[25]  R. Loudon,et al.  Droplet expulsion from the respiratory tract. , 1967, The American review of respiratory disease.

[26]  R. Loudon,et al.  An analysis of 3,485 tuberculosis contacts in the city of Edinburgh during 1954-1955. , 1958, American review of tuberculosis.

[27]  H. Randolph,et al.  TOXIC HEPATITIS WITH JAUNDICE OCCURRING IN A PATIENT TREATED WITH ISONIAZID: REPORT OF A CASE IN A PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA , 1953 .

[28]  D. Kerwin,et al.  FACTS AND FIGURES ABOUT TUBERCULOSIS , 1931 .

[29]  I Sutherland,et al.  Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. , 1976, Advances in tuberculosis research. Fortschritte der Tuberkuloseforschung. Progres de l'exploration de la tuberculose.

[30]  N. Riska,et al.  Characteristics of new cases of active tuberculosis. , 1976, Bulletin of the International Union against Tuberculosis.

[31]  D. Daňková,et al.  Epidemiological and clinical study of tuberculosis in the district of Kolín, Czechoslovakia. Second report (1965-1972). , 1974, Bulletin of the World Health Organization.

[32]  Ferebee Sh.  Controlled chemoprophylaxis trials in tuberculosis. A general review. , 1970 .

[33]  O. Horwitz,et al.  Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. , 1969, Bulletin of the World Health Organization.